Clinical & Experimental Metastasis

, Volume 1, Issue 3, pp 247–259 | Cite as

Brain meninges tumor formation byin vivo-selected metastatic B16 melanoma variants in mice

  • Takanori Kawaguchi
  • Michiko Kawaguchi
  • Karen M. Miner
  • Thomas M. Lembo
  • Garth L. Nicolson


The murine melanoma subline B16-F1 of low brain- and lung-colonizing potential has been used to obtain brain-colonizing variant sublines by sequential selectionin vivo for their abilities to form brain meningeal tumors. After fourteen and fifteen selections in syngeneic C57BL/6 mice sublines B16-B14b and B16–B15b, respectively, were established in culture. These were then assayedin vivo by injection of single tumor cell suspensions into the tail vein (i.v.), left ventricle of the heart (i.c.) or left common carotid artery (i.a.), and the resulting tumors were examined histologically. Injection of subline B16-B14b or B16–B15b resulted in brain meningeal tumor formation in the dura mater and leptomeninges with invasion into underlying brain parenchyma and also some brain ventricular tumors at the sites of i.a. injection. Lung colonization ability remained in the brain-selected sublines, although it was remarkably reduced in i.a. tumor cell-injected animals. The brain meningeal tumors that formed were of three types: intravascular, nodular or infiltrative. Injection of tumor cells i.v. resulted mainly in the establishment of the intravascular type of brain meningeal tumors with eventual perivascular invasion, while injection i.a. or i.c. resulted mostly in nodular or infiltrative type brain meningeal tumors. The B16–B14b brain meningeal tumors formed were small (< 1 mm in diameter) and usually non-pigmented, while B16–B15b tumors were generally large (up to 7mm in diameter) and pigmented. Host reactions towards B16–B14b and B16–B15b tumors at meningeal sites differed. The former B16 subline was characterized by extensive fibrosis with some immunocytic cell infiltration in and around the meningeal tumors, while the latter subline did not elicit such host reactions. In contrast, tumors in brain parenchyma failed to evoke observable host reactions, and there was little evidence of immunocyte cell infiltration or glial cell alterations.


Melanoma Brain Parenchyma Host Reaction Single Tumor Cell Tumor Cell Suspension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Ausman, J. I., Shapiro, W. R., andRall, D. P., 1976, Studies in the chemotherapy of experimental tumors: Development of an experimental model.Cancer Research,30, 2394–2400.Google Scholar
  2. [2]
    Brunson, K. W., Beattie, G., andNicolson, G. L., 1978, Selection and altered properties of brain-colonizing metastatic melanoma.Nature, London,272, 563–566.Google Scholar
  3. [3]
    Brunson, K. W., andNicolson, G. L., 1979, Selection of malignant melanoma variant cell lines for ovary colonization.Journal of Supramolecular Structure,11, 517–528.Google Scholar
  4. [4]
    Conley, F. K., 1979, Development of a metastatic brain tumor model in mice.Cancer Research,30, 1001–1007.Google Scholar
  5. [5]
    Eihorn, L. H., Burgess, M. A., andVallejos, C., 1974, Prognostic correlations and response to treatment in advanced metastatic malignant melanoma.Cancer Research,34, 1995–2004.Google Scholar
  6. [6]
    Fidler, I. J., 1973, Selection of successive tumor lines for metastasis.Nature, London,242, 148–149.Google Scholar
  7. [7]
    Filler, I. J., andKripke, M. L., 1977, Metastasis results from pre-existing variant cells within a malignant tumor.Science (Wash.),197, 893–895.Google Scholar
  8. [8]
    Filler, I. J., andNicolson, G. L., 1981, Immunobiology of experimental metastatic melanoma.Cancer Biology Reviews,2, 171–234.Google Scholar
  9. [9]
    Gershbein, L. L., Benuck, I., andShurrager, P. S., 1975, Brain changes and survival in animal with tumors implanted in the brain.Oncology (Basel),31, 1–16.Google Scholar
  10. [10]
    Grooms, G. A., Elilier, F. R., andMorton, D. L., 1977, Failure of adjuvant immunotherapy to prevent central nervous system metastases in malignant melanoma patients.Journal of Surgical Oncology,9, 147–153.Google Scholar
  11. [11]
    Hustu, H. O., Aur, R. J. A., Verzosa, M. S., Simone, J. V., andPinkel, D., 1973, Prevention of central nervous sytem leukemia by irradiation.Cancer,32, 585–597.Google Scholar
  12. [12]
    Kawaguchi, T. andNakamura, K., 1977, Relationship between transcerebral passage of tumor cells and brain metastasis.Gann,68, 65–71.Google Scholar
  13. [13]
    Miller, B. E., Miller, F. R., andHeppner, G. H., 1981, Interactions between tumor subpopulations affecting their sensitivity to the antineoplastic agents cyclophosphamide and methotrexate.Cancer Research,41, 4378–4381.Google Scholar
  14. [14]
    Miner, K. M., Kawaguchi, T., Uba, G., andNicolson, G. L., 1982, Clonal drift of melanogenic and experimental metastatic properties ofin vivo-selected, brain-colonizing murine melanoma. Cancer Research, 42, 4631–4638.Google Scholar
  15. [15]
    Miner, K. M., Klostergaard, J., Granger, G. A., andNicolson, G. L., 1982, Differential cytolytic and cytostatic effects of inducible factor(s) released from the murine monocytic cell line J774 on metastatic variants of B16 melanomain vitro.Journal of the National Cancer Institute,70, 717–724.Google Scholar
  16. [16]
    Miner, K. M., Lotan, R., andNicolson, G. L., 1981, Metastatic and melanogenic properties ofin vivo-selected B16 melanoma sublines and their Conal derivatives.Phenotypic Expression in Pigment Cells, edited by M. Seiji (Tokyo: University of Tokyo Press), pp. 529–532.Google Scholar
  17. [17]
    Nicolson, G. L., andBrunson, K. W., 1977, Organ specificity of malignant B16 melanomas: In vivo selection for organ preference of blood-borne metastasis.Gann Monograph on Cancer Research,20, 15–24.Google Scholar
  18. [18]
    Olson, M. E., Chernik, N. L., andPosner, J. B., 1974, Infiltration of the leptomeninges by systemic cancer.Archives on Neurology,30, 122–137.Google Scholar
  19. [19]
    Patel, J. K., Didolkar, M. S., Pickrewe, J. W., andMoore, R. H., 1978, Metastatic pattern of malignant melanoma. American Journal of Surgery,135, 807–810.Google Scholar
  20. [20]
    Posner, J. B., 1980, Brain metastases: A clinician's view.Brain Metastasis, edited by L. Weiss, H. A. Gilber and J. B. Posner (Boston: G. K. Hall and Company), pp, 2–29.Google Scholar
  21. [21]
    Poste, G., Doll, J., andFidler, I. J., 1981, Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells.Proceedings of the National Academy of Sciences USA,78, 6226–6230.Google Scholar
  22. [22]
    Proctor, J. W., 1976, Rat sarcoma model supports both “soil seed” and “mechanical” theories of metastatic spread.British Journal of Cancer,34, 651–656.Google Scholar
  23. [23]
    Raz, A., andHart, I. R., 1980, Murine melanoma: A model for intracranial metastasis.British Journal of Cancer,42, 331–341.Google Scholar
  24. [24]
    Robson, A. S., Kirschstein, R. L., andPaul, F. J., 1964, Tumors produced by adenovirus 12 in Mastomys and mice.Journal of the National Cancer Institute,32, 77–87.Google Scholar
  25. [25]
    Sato, H., andSuzuki, M., 1977, Metastasis and chemotherapy, with reference to permeability of the microcirculation system.Cancer Invasion and Metastasis: Biologic Mechanisms and Therapy, edited by S. B. Day, W. P. Laird Mayers, P. Stansley, S. Garattini, and M. G. Lewis (New York: Raven Press), pp. 145–149.Google Scholar
  26. [26]
    Tao, T.-W., Matter, A., Vogel, K., andBurger, M. M., 1979, Liver-colonizing melanoma cells selected from B16 melanoma.International Journal of Cancer,23, 854–857.Google Scholar
  27. [27]
    Tarin, D., andPrice, J. E., 1979, Metastatic colonization potential of primary tumor cells in mice.British Journal of Cancer,39, 740–754.Google Scholar
  28. [28]
    Thomas, L. B., Chirigos, M. A., Humphreys, S. R., andGoldin, A., 1962, Pathology of the spread of L1210 leukemia in the central nervous system of mice and effect of treatment with cytoxan.Journal of the National Cancer Institute,28, 585–597.Google Scholar
  29. [29]
    Ushio, Y., Chernik, N. L., Shapiro, W. R., andPosner, J. B., 1977, Metastatic tumor of the brain: Development of an experimental model.Journal of Neuropathology and Experimental Neurology,36, 20–29.Google Scholar
  30. [30]
    Willis, R. A., 1973, Secondary tumors of the leptomeninges.The Spread of Tumors in the Human Body (London: Butterworths), pp. 259–268.Google Scholar

Copyright information

© Taylor & Francis Ltd 1983

Authors and Affiliations

  • Takanori Kawaguchi
    • 1
  • Michiko Kawaguchi
    • 1
  • Karen M. Miner
    • 1
  • Thomas M. Lembo
    • 1
  • Garth L. Nicolson
    • 1
  1. 1.Department of Tumor Biology, The University of Texas System Cancer CenterM. D. Anderson Hospital and Tumor InstituteHoustonUSA

Personalised recommendations